Why Do We Get Goiters? Causes Go Beyond Iodine Deficiency
- Share via
Key Facts
- Goiter is an abnormal enlargement of the thyroid gland, the butterfly-shaped gland at the base of the neck.
- While iodine deficiency is a major global cause, both too little and too much iodine can increase goiter risk.
- Genetic factors play a key role, with specific gene locations identified that increase susceptibility to goiter.
- Elevated Thyroid-Stimulating Hormone (TSH) and autoimmune diseases like Hashimoto’s are common drivers of thyroid growth.
- Management is highly individualized, ranging from simple observation to supplementation, medication, or surgery depending on the cause.
You see the patient. They have a goiter—an enlarged thyroid. But they live in an iodine-rich country. Eat a good diet. Their labs are normal. So why the swelling? For years, the answer we gave was simple. Too simple. Iodine [1] [2] [3]. Or a lack of it. The thyroid needs iodine to make its hormones. No iodine, the gland gets desperate. It grows bigger, hypertrophies, to try and soak up every last molecule from the blood. A neat story.
Except it wasn’t the whole truth. We started seeing holes in the theory. Goiters in places with plenty of iodine. People in deficient areas with no goiter at all. The story started to fall apart. Then the U-shaped curve data hit [8]. Too little iodine? Bad. But too much iodine? Also bad. This complicated things. Suddenly, our big public health fix—iodized salt—could actually be part of the problem for some. The thyroid wants what it wants. No more, no less.
The mess extends to the gland itself. Goiters aren’t all the same. Some are diffuse, a smooth swelling. Others are nodular. Lumpy. For a long time, we figured nodules were just the end stage of that long, desperate growth from iodine deficiency [10]. But that never felt quite right either. By 2001, we were already pointing out that the iodine story just didn’t explain the facts on the ground [5]. Something else was at play.
That “something else” turned out to be a mix of things. Genetics, for one. We always suspected it; goiters run in families. But a 2011 genome-wide study gave us the proof [9]. It didn’t just hint at a link. It found actual genetic addresses—four of them—tied directly to thyroid size and goiter risk. It’s in the code. Some people are just built to have a bigger thyroid. Nothing to do with their diet.
Then there’s the hormonal engine. Thyroid-Stimulating Hormone, or TSH. It’s the signal from the pituitary gland that tells the thyroid to work. When the gland is sluggish for any reason, the pituitary starts yelling. It cranks up TSH. And that constant hormonal shouting is a powerful growth signal [2] [3] [6]. It makes the thyroid swell. It’s a key pathway. A final common denominator for a lot of goiters.
And you can never, ever talk thyroid without talking about autoimmunity. This is the body attacking itself. In Hashimoto’s, the immune system slowly chews up the gland, and the resulting inflammation and repair attempts make it swell. In Graves’ disease, the immune system makes an antibody that acts like TSH on steroids, flooring the accelerator and making the whole gland grow [4]. These are huge causes of goiter. And they have nothing to do with iodine. It’s a completely different mechanism of disease.
So, the simple model is gone. We’re left with a more complex, messier, but more accurate picture. A goiter isn’t a disease. It’s a sign. A physical clue that points to a whole menu of possible problems.
We still check nutrition. Iodine is still critical. So are other things like selenium and iron [2] [3]. We don’t worry so much about broccoli or cabbage—the so-called goitrogens—unless there’s a real iodine deficiency to begin with. We’re even questioning old villains like smoking; one big study found no real link in an iodine-rich population [7]. Now, we’re even linking nodular goiters to things like metabolic syndrome, tying the thyroid into the body’s overall systemic health [6].
What does this change? It changes how we work. We have to be better detectives. A goiter diagnosis is just the start. Is TSH driving this? Is it autoimmune? Is there a family history? Are the nodules suspicious [4]? The management has to fit the cause. For a small, quiet goiter, the right answer is often just to watch it. If it’s iodine, we supplement [1] [2]. Sometimes we use thyroid hormone to suppress that TSH shouting. And for the big ones, the ones causing symptoms or cosmetic issues, surgery is still the best tool in the box [4].
The neat and tidy story of goiter is history. It’s messy now. It’s genetics. It’s immunity. It’s hormones. The real shift isn’t a new pill. It’s a change in thinking. It’s realizing the enlarged thyroid isn’t the problem itself. It’s a symptom of a deeper story we have to figure out, one patient at a time.
[1] Hughes, K., & Eastman, C. (2012). Goitre - causes, investigation and management. Australian family physician, 41(8), 572–576. https://pubmed.ncbi.nlm.nih.gov/23145396/
[2] Knobel M. (2016). Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. Journal of endocrinological investigation, 39(4), 357–373. https://doi.org/10.1007/s40618-015-0391-7
[3] Medeiros-Neto, G., Camargo, R. Y., & Tomimori, E. K. (2012). Approach to and treatment of goiters. The Medical clinics of North America, 96(2), 351–368. https://doi.org/10.1016/j.mcna.2012.01.010
[4] Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Jr, Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., Newbold, K., Nikiforov, Y. E., Randolph, G., Rosenthal, M. S., Sawka, A. M., Shah, M., Shaha, A., Smallridge, R., & Wong-Clark, C. K. (2021). 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid : official journal of the American Thyroid Association, 31(3), 337–386. https://doi.org/10.1089/thy.2020.0944
[5] Derwahl, M., & Studer, H. (2001). Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 109(5), 250–260. https://doi.org/10.1055/s-2001-16344
[6] Yildirim Simsir, I., Cetinkalp, S., & Kabalak, T. (2020). Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 29(1), 1–5. https://doi.org/10.1159/000503575
[7] Karatoprak, C., Kartal, I., Kayatas, K., Ozdemir, A., Yolbas, S., Meric, K., & Demirtunc, R. (2012). Does smoking affect thyroid gland enlargement and nodule formation in iodine-sufficient regions?. Annales d’endocrinologie, 73(6), 542–545. https://doi.org/10.1016/j.ando.2012.09.008
[8] Yu, X., Fan, C., Shan, Z., Teng, X., Guan, H., Li, Y., Teng, D., Jin, Y., Chong, W., Yang, F., Dai, H., Yu, Y., Li, J., Chen, Y., Zhao, D., Shi, X., Hu, F., Mao, J., Gu, X., Yang, R., … Teng, W. (2008). A five-year follow-up study of goiter and thyroid nodules in three regions with different iodine intakes in China. Journal of endocrinological investigation, 31(3), 243–250. https://doi.org/10.1007/BF03345597
[9] Teumer, A., Rawal, R., Homuth, G., Ernst, F., Heier, M., Evert, M., Dombrowski, F., Völker, U., Nauck, M., Radke, D., Ittermann, T., Biffar, R., Döring, A., Gieger, C., Klopp, N., Wichmann, H. E., Wallaschofski, H., Meisinger, C., & Völzke, H. (2011). Genome-wide association study identifies four genetic loci associated with thyroid volume and goiter risk. American journal of human genetics, 88(5), 664–673. https://doi.org/10.1016/j.ajhg.2011.04.015
[10] Teumer, A., Rawal, R., Homuth, G., Ernst, F., Heier, M., Evert, M., Dombrowski, F., Völker, U., Nauck, M., Radke, D., Ittermann, T., Biffar, R., Döring, A., Gieger, C., Klopp, N., Wichmann, H. E., Wallaschofski, H., Meisinger, C., & Völzke, H. (2011). Genome-wide association study identifies four genetic loci associated with thyroid volume and goiter risk. American journal of human genetics, 88(5), 664–673. https://doi.org/10.1016/j.ajhg.2011.04.015
